1,3-dipropyl-8-cyclopentylxanthine has been researched along with Hyperprolactinemia in 1 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
Hyperprolactinemia: Increased levels of PROLACTIN in the BLOOD, which may be associated with AMENORRHEA and GALACTORRHEA. Relatively common etiologies include PROLACTINOMA, medication effect, KIDNEY FAILURE, granulomatous diseases of the PITUITARY GLAND, and disorders which interfere with the hypothalamic inhibition of prolactin release. Ectopic (non-pituitary) production of prolactin may also occur. (From Joynt, Clinical Neurology, 1992, Ch36, pp77-8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fideu, MD | 1 |
| Arce, A | 1 |
| Miras-Portugal, MT | 1 |
| Esquifino, AI | 1 |
1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Hyperprolactinemia
| Article | Year |
|---|---|
Prolactin and cyclosporine modulate adenosine transporters and adenosine A1 receptors in the rat brain.
Topics: Adenosine; Animals; Brain; Carrier Proteins; Cyclosporine; Female; Hyperprolactinemia; Male; Membran | 2000 |